ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 35 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 5,554,925 | $2,750,000 | 0.42% |
| SABBY MANAGEMENT, LLC | 900,000 | $446,000 | 0.30% |
| Sio Capital Management, LLC | 1,270,758 | $629,000 | 0.24% |
| Vivo Capital, LLC | 2,840,909 | $1,406,000 | 0.14% |
| Waterfront Wealth Inc. | 353,000 | $175,000 | 0.07% |
| DAFNA Capital Management LLC | 343,720 | $170,000 | 0.05% |
| RTW INVESTMENTS, LP | 3,250,000 | $1,609,000 | 0.04% |
| Ikarian Capital, LLC | 970,747 | $185,000 | 0.03% |
| MYDA Advisors LLC | 150,000 | $74,000 | 0.02% |
| Temasek Holdings (Private) Ltd | 1,678,075 | $830,647 | 0.01% |